Uppsala, Sweden

Monica Einarsson

This inventor holds 2 USPTO granted patents. Top assignees: Pharmacia & Upjohn Ab, Pharmacia & Upjohn Aktiebolag. Active years: 1997-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Monica Einarsson. Retrieved from https://idiyas.com/inventor/monica-einarsson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.5

ph-index = 2

Forward Citations = 188(Granted Patents)


Company Filing History:


Years Active: 1997-1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Monica Einarsson: Innovator in Pharmaceutical Compositions

Introduction

Monica Einarsson is a notable inventor based in Uppsala, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance drug delivery systems. With a total of 2 patents, her work has the potential to impact various medical applications.

Latest Patents

Monica's latest patents include a pharmaceutical composition containing heparin and heparin fragments. Another significant patent involves a defined lipid system that includes at least two lipid components, where one is amphiphatic and polar, and the other is nonpolar. These compositions are designed to include a water-containing solvent, allowing for the presence of discrete lipid particles. This innovation can be adapted for various administration forms, such as rectal, oral, buccal, and transdermal routes.

Career Highlights

Throughout her career, Monica has worked with prominent companies in the pharmaceutical industry, including Pharmacia & Upjohn AB and Pharmacia & Upjohn Aktiebolag. Her experience in these organizations has contributed to her expertise in pharmaceutical innovations.

Collaborations

Monica has collaborated with notable professionals in her field, including Hangkan Nyqvist and Christer Mattsson. These partnerships have likely enriched her research and development efforts.

Conclusion

Monica Einarsson's contributions to pharmaceutical compositions demonstrate her innovative spirit and dedication to improving drug delivery systems. Her patents reflect a commitment to advancing medical science and enhancing patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…